Ground Fluor Pharmaceuticals Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Ground Fluor Pharmaceuticals General Information

Description

Developer of medical imaging products designed to focus on fluorine synthesis for positron emitting tomography imaging. The company's proprietary chemical technologies develop a synthesis of pharmaceutical compounds, such as Fluorine F-18 Agents, and develop and provide imaging agents for positron emission tomography scans, thereby enabling clients to produce fluorine in much higher yields, with much higher potency.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2124 Y Street
  • Flat 101
  • Lincoln, NE 68503
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • 2124 Y Street
  • Flat 101
  • Lincoln, NE 68503
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ground Fluor Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 09-Jun-2016 Completed Generating Revenue
4. Early Stage VC 17-Apr-2014 Completed Startup
3. Grant 03-Apr-2014 Completed Startup
2. Grant 14-Jun-2012 $150K Completed Startup
1. University Spin-Out 01-Jan-2012 Completed Startup
To view Ground Fluor Pharmaceuticals’s complete valuation and funding history, request access »

Ground Fluor Pharmaceuticals Patents

Ground Fluor Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014152431-A1 Stabilization of radioiodinated and astatinated pharmaceutials and imaging agents Inactive 15-Mar-2013
US-20140275539-A1 Stabilization of radioiodinated and astatinated pharmaceuticals and imaging agents Inactive 15-Mar-2013
AU-2013334166-A1 Processes and reagents for making diaryliodonium salts Inactive 27-Oct-2012
CA-2889575-A1 Processes and reagents for making diaryliodonium salts Inactive 27-Oct-2012
EP-2912011-A1 Processes and reagents for making diaryliodonium salts Inactive 27-Oct-2012 C07D475/04
To view Ground Fluor Pharmaceuticals’s complete patent history, request access »

Ground Fluor Pharmaceuticals Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cedarville Investments Venture Capital Minority
US National Science Foundation Accelerator/Incubator
To view Ground Fluor Pharmaceuticals’s complete investors history, request access »

Ground Fluor Pharmaceuticals FAQs

  • When was Ground Fluor Pharmaceuticals founded?

    Ground Fluor Pharmaceuticals was founded in 2012.

  • Where is Ground Fluor Pharmaceuticals headquartered?

    Ground Fluor Pharmaceuticals is headquartered in Lincoln, NE.

  • What industry is Ground Fluor Pharmaceuticals in?

    Ground Fluor Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Ground Fluor Pharmaceuticals a private or public company?

    Ground Fluor Pharmaceuticals is a Private company.

  • What is Ground Fluor Pharmaceuticals’s current revenue?

    The current revenue for Ground Fluor Pharmaceuticals is .

  • Who are Ground Fluor Pharmaceuticals’s investors?

    Cedarville Investments and US National Science Foundation have invested in Ground Fluor Pharmaceuticals.

  • When was Ground Fluor Pharmaceuticals acquired?

    Ground Fluor Pharmaceuticals was acquired on 09-Jun-2016.

  • Who acquired Ground Fluor Pharmaceuticals?

    Ground Fluor Pharmaceuticals was acquired by FluoroPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process